Membranous nephritis

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Membranous nephritis Classification and external resources
ICD-10	N00.-N08., with .2 suffix
ICD-9	581.1, 582.1 , 583.1
DiseasesDB	7970
MedlinePlus	000472
eMedicine	med/885

Membranous nephropathy (or membranous nephritis, or membranous glomerulonephritis) is an immunologic renal disorder characterized by subepithelial immune deposits in the glomerular capillary wall. The subepithelial deposits are antigen-antibody complexes. They are formed by antibodies against cationic antigens crossing the anionic glomerular barrier or by circulating antigens. Although primary membranous predominantly has subepithelial deposits, secondary membranous may be characterized by subendothelial deposits and mesangial deposits. Rheumatoid arthritis itself can be associated with secondary MN. Drugs associated with rheumatoid arthritis such as penicillamine, gold salts, and some NSAIDs (such as Diclofenac) can also be associated with membranous nephritis. Other diseases associated with MN include lupus nephritis (WHO class V), Sjögren's syndrome, sarcoidosis, Hepatitis B virus, Hepatitis C virus. The only MN with a low complement level are lupus nephritis and Hepatitis B Virus (associated with elevated transaminases, Hepatitis B antigens).

Diagnosis

Membranous nephritis can be diagnosed by histological observation. Light microscopy with H&E stain may reveal thickened capillary walls. Fluorescence microscopy may reveal immunoglobulins in a granular pattern along the capillary wall. Jones (silver stain) may reveal spikes or holes corresponding to the immune deposits. Electron microscopy reveals electron dense deposits intramembranously or in the subepithelial space.

Prognosis

The prognosis for membranous nephritis is variable. In many cases, there is spontaneous remission. Therefore, many patients will not require treatment. However, in patients who have decreasing renal function and a high level of proteinuria (nephrotic range, and often around 10g), therapy using steroids and cytotoxics may be necessary. Cyclophosphamide and steroids have been used in some studies with success. In refractory cases, ciclosporin may also be useful. Some recent studies have tried mycophenolate mofetil with success.

References

Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol. 2007 Jun;18(6):1899-904.